
Hydroquinone: Treats selected hyperpigmentation, including melasma, under an appropriate treatment plan. Vitamin C: Some topical formulas modestly improve photodamaged skin and uneven tone.


Choose for diagnosed stubborn pigment with professional guidance and a defined review point.
Choose for an optional antioxidant and modest photoaging benefits; formula stability matters.
Can you use both?
Use vitamin C in the morning and hydroquinone at night.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Acts on tyrosinase pathways: Hydroquinone suppresses melanin synthesis. Targets excess pigmentation: Appropriate use and monitoring matter.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Helps limit oxidation: Ascorbic acid neutralizes reactive molecules. Supports collagen enzymes: It is a cofactor in collagen production.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
4% is a common clinician-directed hydroquinone strength. In the U.S., hydroquinone skin-lightening products are not legally marketed over the counter; higher compounded strengths are not routine starting points.
4%
Clinician-directed strength
Used in melasma treatment and in the approved combination TRI-LUMA. Treatment length and the complete formula require medical guidance.
Choosing a strength: Get a diagnosis and a treatment plan for the pigmented area rather than choosing solely by concentration.
Higher strengths: More is not automatically better. Irritation and blue-black discoloration called ochronosis are important risks, especially with inappropriate or prolonged use.
Formula matters: Single-ingredient creams, compounded blends and TRI-LUMA are different products. A combination containing a steroid or retinoid needs its own instructions.
Vitamin C percentages only make sense when the form is named. Human studies include 5% L-ascorbic acid cream and a 15% L-ascorbic acid antioxidant combination; derivatives are different ingredients.
5%
15%
20%
Studied L-ascorbic acid cream
A lower-strength finished cream studied for photoaged skin. A modest percentage can still have clinical evidence.
Studied antioxidant combination
Studied with vitamin E and ferulic acid. The result supports that combination, not vitamin C in every formula.
Absorption-study benchmark
A pig-skin study found maximal delivery at this concentration under its test conditions. It is not proof of the best clinical dose.
Choosing a strength: Check whether the product contains L-ascorbic acid or a derivative. Percentages of different forms are not interchangeable.
Higher strengths: A higher number is not automatically better and may be less comfortable. A laboratory delivery result is not a recommendation to maximize strength.
Formula matters: Acidity, stability, packaging and the other ingredients affect performance. A derivative serum cannot be ranked against L-ascorbic acid by percentage alone.
Approximate windows, not promises.
First few weeksAssess tolerance first; pigment change is usually slower.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksSome studied regimens begin showing pigment improvement.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksA useful review point for benefit and irritation.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Can irritate; prolonged inappropriate use can cause paradoxical darkening (ochronosis).
Acidic formulas may sting; stop for persistent redness or a rash.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Do not use to lighten normal skin broadly or continue through worsening pigmentation. US nonprescription hydroquinone skin-lightening products are not legally marketed.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
More of it is absorbed through the skin than with most topicals, so it is usually stopped. Azelaic acid is the common substitute. Ask the doctor managing your pregnancy.
Topical vitamin C is generally considered acceptable in pregnancy; check the complete formula with your clinician.
On the skin. The finished product delivers hydroquinone in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Suppresses melanin synthesis through tyrosinase-related activity; targeted use and monitoring matter.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers vitamin c in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Ascorbic acid participates in antioxidant and collagen pathways; stability and delivery limit topical performance.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Choose for diagnosed stubborn pigment with professional guidance and a defined review point.
The reviewed active-comparator melasma study was small with substantial attrition. Hydroquinone has broader clinical use, but this comparison does not support indefinite treatment or unsupervised high strengths.
Choose for an optional antioxidant and modest photoaging benefits; formula stability matters.
Small controlled trials support specific formulas over three to six months. Derivatives have different masses and evidence; they cannot be assumed interchangeable with L-ascorbic acid.
Sources